Protai Bio
Latest round
- Seed
Last raised
- Mar 2023
Total raised
- $20M
Investors
- 3
About Protai Bio
Based in Tel Aviv, Israel, and founded in 2021, Protai Bio Ltd operates as an artificial intelligence (AI)-powered drug discovery company. Eran Seger (CEO) and Kirill Prevzner (CTO) are the co-founders of the company. The company provides an end-to-end AI-based platform that thoroughly maps the course of the disease at the protein level, boosting the capacity to observe cellular function and, as a result, the discovery of new medications.
Who invested in Protai Bio
3 investors across 2 rounds
See all investors in Protai Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Protai Bio
Who invested in Protai Bio?
Protai Bio has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Protai Bio raised?
Protai Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Protai Bio last raise money?
Protai Bio's most recent round on record is a Seed, in Mar 2023.
What does Protai Bio do?
Based in Tel Aviv, Israel, and founded in 2021, Protai Bio Ltd operates as an artificial intelligence (AI)-powered drug discovery company.
Where is Protai Bio headquartered?
Protai Bio is headquartered in Tel Aviv, Israel.
Which VCs invest in companies like Protai Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Protai Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Protai Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.